Effectiveness of CBT: Success Rate Statistics in the U.S. (2026)
Cognitive behavioral therapy (CBT) is a structured, time-limited talk therapy that helps people identify and change unhelpful thoughts and behaviors. It is also one of the most heavily tested treatments in mental health: a 2023 meta-analysis in World Psychiatry pooled 409 randomized controlled trials (RCTs) covering 52,702 patients with depression alone.
The question of how well CBT works carries real public health weight. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), 52.1% of U.S. adults with any mental illness received treatment in 2024. That leaves a large share of people who could benefit from an option with a strong evidence base, such as CBT. Interest in the cognitive behavioural therapy success rate, as it is spelled outside the U.S., reflects that same demand for proven care.
Most data on the effectiveness of CBT comes from international trials rather than U.S.-only studies, and results vary by condition, age group and delivery format. "Success rate" is also not a single number, since researchers measure response, remission and effect size separately.
Keep reading to learn how effective cognitive behavioral therapy is, how the CBT success rate is measured, and how it compares with medication.
Key Takeaways:
A January 2023 meta-analysis of 409 trials and 52,702 adults with depression found CBT produced a moderate-to-large effect (g = 0.79) versus control conditions (Cuijpers et al., World Psychiatry).
Among children and adolescents with anxiety disorders, 49.4% reached remission after CBT, nearly 3x the 17.8% rate on a waitlist (Cochrane review, November 2020).
At 6 to 12 months after treatment, adults with depression treated with CBT fared better than those treated with medication alone (g = 0.34), though few trials measured this (Cuijpers et al., January 2023).
Trauma-focused therapies, including CBT-based approaches, led to loss of a post-traumatic stress disorder (PTSD) diagnosis in 65% to 86% of non-military patients (JAMA Psychiatry, May 2025).
52.1% of U.S. adults with any mental illness received mental health treatment in 2024, indicating substantial room to expand access to proven therapies (SAMHSA, July 2025).
How the CBT Success Rate Is Measured?
There is no single "CBT success rate." Clinical studies report three distinct measures, and each one answers a slightly different question. Comparing figures without checking which measure was used is the most common source of confusion in CBT statistics.
CBT Response Rate:
A patient is usually counted as a "responder" when symptom scores drop by 50% or more from baseline. Response captures meaningful improvement, even if some symptoms remain. It is typically the highest of the three figures reported in a given study.
CBT Remission Rate:
Remission means symptoms have fallen below the threshold used to diagnose the condition. It is a stricter benchmark than response, so remission rates run lower. For patients, remission is often the more practical goal, since it signals a return to normal functioning.
CBT Effect Size and NNT Statistics:
Effect size, most often reported as Hedges' g, measures how far the average treated patient moves compared with an untreated group. By common convention, 0.2 is small, 0.5 is moderate and 0.8 is large.
Researchers also use the number needed to treat (NNT), which estimates how many patients must receive a treatment for 1 additional patient to benefit. A lower NNT indicates a stronger treatment.
Measure | What it shows | Typical threshold |
Response | Meaningful symptom improvement | ≥50% drop in symptom score |
Remission | Symptoms below diagnostic level | Below a clinical cutoff |
Effect size (g) | Size of benefit vs control | 0.2 small, 0.5 moderate, 0.8 large |
NNT | Patients treated per extra success | Lower is better |
General Statistics on the Effectiveness of CBT:
Here are some general statistics on the effectiveness of CBT and the evidence base for CBT, drawn from the largest available reviews.
Evidence Base for CBT: Trials and Meta-Analyses
Cuijpers et al. reported 409 RCTs and 518 comparisons involving 52,702 patients with depression in January 2023, making CBT one of the most studied psychotherapies for the condition.
Hofmann et al. identified 269 meta-analyses of CBT and reviewed a representative sample of 106 in July 2012.
The same 2012 review found the strongest support for CBT in anxiety disorders, somatoform disorders, bulimia, anger control problems and general stress.
What Is the Overall Success Rate of CBT?
Most headline figures on the success rate of CBT come from depression research, which has the deepest trial base. Results for other conditions appear in the next section.
CBT produced an effect size of g = 0.79 versus care as usual and waitlist controls among adults with depression, as reported by Cuijpers et al. in January 2023.
~42% of patients receiving CBT for depression responded to treatment, more than double the ~19% response rate in control groups, according to published summaries of the same 2023 analysis.
~36% of CBT patients reached remission, compared with ~15% in control conditions, representing roughly 2.4x the remission rate.
The corresponding NNT was ~4.7 for response and ~3.6 for remission, meaning roughly 1 in every 4 patients treated gained a benefit they would not otherwise have had.
Outcome (adult depression) | CBT | Control | Source |
Effect size vs control | g = 0.79 | N/A | Cuijpers et al., Jan 2023 |
Response rate | ~42% | ~19% | Cuijpers et al., Jan 2023* |
Remission rate | ~36% | ~15% | Cuijpers et al., Jan 2023* |
NNT (remission) | ~3.6 | N/A | Cuijpers et al., Jan 2023* |
U.S. Mental Health Treatment Rates and Access to CBT
U.S. survey data does not track CBT specifically, but it does show how many people receive any form of mental health treatment.
52.1% of U.S. adults with any mental illness (AMI) received mental health treatment in the past year, according to SAMHSA's 2024 National Survey on Drug Use and Health (NSDUH), released in July 2025.
60.6% of U.S. adolescents aged 12 to 17 who had a major depressive episode (MDE) received treatment in 2024, per the same survey.
Read constructively, these figures show that roughly half of affected adults are already engaged in care, and that well-tested therapies such as CBT have clear room to reach more people.
CBT Success Rates by Condition:
Here is how the CBT success rate varies across the conditions where it has been studied most. Effect sizes are not directly comparable across conditions, because each study used different measures and control groups.
Condition | Population | Key outcome | Source and date |
Depression | Adults | g = 0.79 vs control; ~36% vs ~15% remission | Cuijpers et al., Jan 2023 |
Anxiety disorders | Children and teens | 49.4% vs 17.8% remission | Cochrane (James et al.), Nov 2020 |
PTSD | Non-military adults | 65% to 86% lost PTSD diagnosis | Smolenski et al., JAMA Psychiatry, May 2025 |
PTSD | Military and veterans | 44% to 50% lost PTSD diagnosis | Smolenski et al., May 2025 |
Insomnia (CBT-I) | Adults | Sleep efficiency up ~9.9 percentage points | Trauer et al., Annals of Internal Medicine, Aug 2015 |
OCD | Adults | Effect size 1.31 vs waitlist | Öst et al., Clinical Psychology Review, Aug 2015 |
CBT Success Rate for Depression:
CBT outperformed care as usual and waitlist controls with an effect size of g = 0.79 among adults with depression (Cuijpers et al., January 2023).
The benefit versus control conditions remained significant at 6 to 12 months of follow-up in the same analysis.
CBT Success Rate for Anxiety Disorders:
Hofmann et al. reported in July 2012 that anxiety disorders had among the strongest support for CBT across 106 reviewed meta-analyses.
In young people, 49.4% of those treated with CBT were free of their primary anxiety diagnosis after treatment, compared with 17.8% without treatment (Cochrane, November 2020).
CBT Success Rate for PTSD:
Trauma-focused therapies such as cognitive processing therapy (CPT) and prolonged exposure (PE) are CBT-based treatments for post-traumatic stress disorder (PTSD).
Smolenski et al. reported in May 2025 that 65% to 86% of non-military patients no longer met PTSD criteria after trauma-focused treatment, across 34 trials and 3,208 participants.
Among military service members and veterans, 44% to 50% lost their diagnosis after CPT or PE. The lower range likely reflects more complex, combat-related trauma, and still means nearly half of these patients no longer met criteria.
CBT-I Success Rate for Insomnia:
Cognitive behavioral therapy for insomnia (CBT-I) adapts CBT to sleep habits and beliefs about sleep.
Trauer et al. reported in August 2015 that CBT-I cut the time needed to fall asleep by ~19 minutes, across 20 trials and 1,162 participants.
Time spent awake after first falling asleep fell by ~26 minutes, and sleep efficiency rose by ~9.9 percentage points.
Total sleep time increased by ~7.6 minutes, though this change was not statistically certain, so the gains appear to come mainly from better-quality sleep.
CBT Success Rates for OCD and Eating Disorders:
For obsessive-compulsive disorder (OCD), the main CBT method is exposure and response prevention (ERP).
Öst et al. reported in August 2015 that CBT for OCD produced effect sizes of 1.31 versus waitlist and 1.33 versus placebo across 37 RCTs, both well above the 0.8 "large" threshold.
The same review found CBT outperformed antidepressant medication for OCD, with an effect size of 0.55.
For eating disorders, Hofmann et al. listed bulimia among the conditions with the strongest CBT support in July 2012; pooled remission figures vary widely across studies.
CBT Success Rate Statistics for Children and Teens:
Here is what the research shows about the CBT success rate for children and teens, including one of the largest U.S.-based trials.
CBT Remission Rates for Childhood Anxiety:
A Cochrane review published in November 2020 analyzed 87 studies with 5,964 children and adolescents.
49.4% of young people treated with CBT reached remission of their primary anxiety diagnosis, versus 17.8% on a waitlist or receiving no treatment.
CBT also improved remission across all anxiety diagnoses (odds ratio 4.43).
The signal is mixed when CBT is compared with other active treatments: the review found little evidence that CBT outperformed alternatives, though data was limited and of low quality.
CBT Response Rates for Teen Depression
The Treatment for Adolescents with Depression Study (TADS), funded by the National Institute of Mental Health (NIMH), remains a key U.S. data source.
TADS enrolled 439 adolescents aged 12 to 17 at 13 U.S. clinics, with results published in JAMA in August 2004.
After 12 weeks, 71.0% of teens receiving CBT plus fluoxetine responded, the highest rate among the four groups.
Response reached 60.6% with fluoxetine alone, 43.2% with CBT alone and 34.8% with placebo.
The findings suggest that combining CBT with medication offers the strongest short-term results for moderate-to-severe teen depression.
60.6% of U.S. teens with a major depressive episode received treatment in 2024 (SAMHSA, July 2025), so combined approaches can reach a sizable group already in care.
How Effective Is Cognitive Behavioral Therapy Compared With Other Treatments?
Here is how effective cognitive behavioral therapy is compared with medication, other talk therapies and combined treatment, based on the January 2023 World Psychiatry analysis of adult depression.
Comparison | Short-term result | Long-term result (6 to 12 months) |
CBT vs other psychotherapies | CBT slightly ahead (g = 0.06), not robust | Not significant |
CBT vs medication | No significant difference | CBT ahead (g = 0.34), few trials |
CBT + medication vs medication alone | Combined ahead (g = 0.51) | Combined ahead (g = 0.32) |
CBT + medication vs CBT alone | No significant difference | No significant difference |
CBT vs Medication: Success Rate Comparison:
Cuijpers et al. found no significant short-term difference between CBT and antidepressant medication for adult depression in January 2023.
At 6 to 12 months, CBT was more effective than medication (g = 0.34), although few trials tracked this and the result did not hold in every sensitivity analysis.
For OCD, Öst et al. reported in August 2015 that CBT outperformed medication with an effect size of 0.55.
CBT vs Other Therapies: Effectiveness Statistics:
CBT's advantage over other psychotherapies for depression was small (g = 0.06) and lost significance in most sensitivity analyses (Cuijpers et al., January 2023).
This suggests several structured talk therapies perform similarly, which widens the range of effective options available to patients.
CBT Plus Medication: Combined Treatment Statistics:
Combined treatment outperformed medication alone for adult depression both short term (g = 0.51) and long term (g = 0.32), per Cuijpers et al. in January 2023.
Combined treatment was not significantly better than CBT alone at either time point.
In teens, TADS reported a 71.0% response rate for combined treatment in August 2004, versus 43.2% for CBT alone.
Long-Term CBT Success Rates and Relapse Statistics:
Here is what the data shows about how long the CBT success rate holds and how relapse risk compares with medication.
Do CBT Success Rates Hold Over Time?
The benefits of CBT for adult depression remained statistically significant at 6 to 12 months of follow-up, according to Cuijpers et al. in January 2023.
CBT's edge over medication emerged mainly at follow-up (g = 0.34), consistent with the idea that skills learned in therapy keep working after sessions end.
Relapse Rates After CBT vs After Stopping Medication:
Breedvelt et al. reported in May 2021 that adding a psychological intervention while tapering antidepressants protected against relapse about as well as staying on medication (hazard ratio 0.86, not statistically significant).
The analysis pooled individual data from 4 RCTs and 712 participants with depression.
About 46% of participants across both groups relapsed during follow-up, which underscores the value of ongoing relapse-prevention planning whichever treatment path is chosen.
Online and App-Based CBT Effectiveness Statistics:
Here are the latest statistics on the effectiveness of CBT delivered digitally, a format that can reduce cost, travel and wait-time barriers.
Guided Online CBT Success Rates:
A meta-analysis published in Cognitive Behaviour Therapy in January 2018 found that guided internet-based CBT (iCBT) and face-to-face CBT produced equivalent results (g = 0.05, not significant).
The review covered 20 RCTs and 1,418 participants with psychiatric and somatic conditions.
Self-Guided CBT App Effectiveness:
Linardon et al. reported in February 2024 that mental health smartphone apps produced small effects for depression (g = 0.28) and generalized anxiety (g = 0.26), based on 176 RCTs.
The NNT was ~11.5 for depression and ~12.4 for anxiety, notably higher than the ~3.6 to ~4.7 range estimated for therapist-delivered CBT.
Apps that included CBT features produced significantly larger effects for depression, suggesting that CBT principles strengthen digital tools even without a therapist.
Get Evidence-Based CBT at The Renew Center of Florida
With one of the largest evidence bases for CBT of any talk therapy, CBT has been extensively studied, with strong evidence for depression, anxiety, PTSD, insomnia and OCD. If you are weighing treatment options, The Renew Center of Florida offers evidence-based cognitive behavioral therapy with licensed clinicians.
FAQs:
What is the success rate of CBT?
There is no single success rate of CBT, but for adult depression ~42% of CBT patients respond to treatment versus ~19% of untreated patients. That figure comes from a January 2023 meta-analysis of 409 trials. Remission, a stricter measure, reached ~36% versus ~15%. Success rates are higher for some conditions, such as anxiety and OCD, so the right figure depends on the condition being treated.
How common is CBT and therapy use in the U.S.?
National surveys do not track CBT specifically, but treatment use is widespread. SAMHSA reported that 52.1% of U.S. adults with any mental illness received mental health treatment in 2024. Among teens with a major depressive episode, 60.6% received treatment. CBT is among the most commonly recommended approaches within that care, given its large evidence base of 269 identified meta-analyses as of 2012.
Is CBT more effective than medication?
In the short term, CBT and antidepressants perform about equally for adult depression, according to a January 2023 meta-analysis. At 6 to 12 months, CBT showed an advantage (g = 0.34), though few trials measured this. Combining CBT with medication outperformed medication alone. Treatment choice depends on symptom severity and personal preference, and should be made with a qualified clinician.
Does the CBT success rate last, or do people relapse?
CBT's benefits for depression generally persist, remaining significant at 6 to 12 months of follow-up in the largest available analysis. A May 2021 study found that therapy during antidepressant tapering prevented relapse about as well as continuing medication. Relapse still occurred in about 46% of participants across groups, so ongoing relapse-prevention planning remains valuable after treatment ends.
Which conditions have the highest CBT success rate?
CBT shows its strongest effects for OCD, anxiety disorders and PTSD. For OCD, effect sizes reached 1.31 versus waitlist in a 2015 review of 37 trials. Trauma-focused CBT led 65% to 86% of non-military patients to lose their PTSD diagnosis in a May 2025 analysis. A 2012 review of meta-analyses also highlighted bulimia, anger problems and general stress.
How long does CBT take to work?
Most CBT programs are short-term, and many trials measure results after about 12 weeks of weekly sessions. In the U.S.-based TADS trial, teen response rates were assessed at 12 weeks. Some people notice improvement earlier, while complex or long-standing conditions may need longer courses. A clinician can estimate a realistic timeline after an initial assessment.
What is the CBT success rate for teenagers?
Yes, CBT is effective for many teens, particularly for anxiety. A November 2020 Cochrane review found 49.4% of young people reached remission from anxiety after CBT, versus 17.8% without treatment. For teen depression, the TADS trial found CBT combined with fluoxetine produced the highest response rate, at 71.0% after 12 weeks, compared with 43.2% for CBT alone.
Is online CBT as effective as in-person therapy?
Therapist-guided online CBT appears to work about as well as face-to-face CBT. A 2018 meta-analysis of 20 trials found no meaningful difference between the two formats (g = 0.05). Self-guided apps show smaller benefits (g = 0.28 for depression in a 2024 review of 176 trials), though apps built on CBT principles performed better than others.
Data Sources
World Psychiatry (2023): Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression, Cuijpers P, Miguel C, Harrer M, et al.
Cognitive Therapy and Research (2012): The Efficacy of Cognitive Behavioral Therapy, A Review of Meta-analyses, Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A.
Cochrane Review (2020): Cognitive behavioural therapy for anxiety disorders in children and adolescents, James AC, Reardon T, Soler A, James G, Creswell C.
JAMA (2004): Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression, Treatment for Adolescents With Depression Study (TADS) Team.
SAMHSA (2025): 2024 National Survey on Drug Use and Health, Mental Health Treatment Among Adults and Adolescents, Substance Abuse and Mental Health Services Administration.
